SG Americas Securities LLC Lowers Position in Simulations Plus, Inc. (NASDAQ:SLP)

SG Americas Securities LLC cut its holdings in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 4.3% in the 3rd quarter, HoldingsChannel reports. The firm owned 25,969 shares of the technology company’s stock after selling 1,173 shares during the quarter. SG Americas Securities LLC’s holdings in Simulations Plus were worth $832,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. EntryPoint Capital LLC purchased a new stake in Simulations Plus in the 1st quarter worth about $57,000. Allspring Global Investments Holdings LLC bought a new position in Simulations Plus in the 1st quarter worth about $70,000. Los Angeles Capital Management LLC bought a new position in Simulations Plus in the 2nd quarter worth about $206,000. Arizona State Retirement System bought a new position in Simulations Plus in the 2nd quarter worth about $218,000. Finally, Connecticut Wealth Management LLC bought a new position in Simulations Plus in the 1st quarter worth about $204,000. 78.08% of the stock is owned by hedge funds and other institutional investors.

Simulations Plus Trading Up 2.9 %

Shares of NASDAQ SLP opened at $31.24 on Friday. The stock has a market cap of $625.05 million, a price-to-earnings ratio of 65.08 and a beta of 0.69. Simulations Plus, Inc. has a 1-year low of $29.37 and a 1-year high of $51.22. The stock’s 50-day moving average is $33.87 and its 200 day moving average is $41.32.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the company. William Blair restated an “outperform” rating on shares of Simulations Plus in a research note on Thursday, September 12th. JMP Securities initiated coverage on Simulations Plus in a research report on Tuesday, July 16th. They set a “market perform” rating for the company. Craig Hallum reiterated a “buy” rating and set a $56.00 price target on shares of Simulations Plus in a research report on Wednesday, July 3rd. Finally, KeyCorp initiated coverage on Simulations Plus in a research report on Monday, July 29th. They set an “overweight” rating and a $47.00 price target for the company. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $56.00.

Insider Activity at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $35.18, for a total transaction of $703,600.00. Following the transaction, the director now directly owns 3,501,592 shares of the company’s stock, valued at approximately $123,186,006.56. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. In the last three months, insiders have sold 60,750 shares of company stock valued at $2,145,055. Corporate insiders own 20.90% of the company’s stock.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.